Blog

Tech Nation Visa: the gateway to world-leading UK tech jobs

At BenevolentAI we are always on the lookout for exceptional people to join us on our mission to re-engineer drug discovery and deliver life changing medicines to patients.


Our teams are curious, open to new ideas and passionate about making a positive impact on the world. At BenevolentAI we value different experiences, skills, and backgrounds and believe a diverse and inclusive environment is necessary to push technological and scientific boundaries. 

A globally diverse perspective is important, which is why we encourage the best tech talent from around the world to join us. As such, we want to draw attention to the Tech Nation Visa, also known as the Global Talent Visa in digital technology, which is a great initiative that enables the brightest international talent to live and work in the UK. 

Tech Nation, a close partner of BenevolentAI, has been designated by the Home Office to endorse applications for this Visa.  The application process is based on your unique background, skills, and achievements and there are two pathways to apply, depending on your experience:  Exceptional Talent and Exceptional Promise. The Tech Nation visa is highly flexible, not tied to a specific job, company or location. Applicants can have experience in any tech subsector and either business or technical backgrounds. It is granted for up to 5 years, with the ability to extend as many times as required. The Tech Nation Visa can also lead to permanent residency here in the UK.

Whether you have an established career in tech, or are finding your feet, the UK’s flourishing tech scene provides rich opportunities for entrepreneurs to set up or scale a business, or find employment at an existing firm. 52% of those endorsed last year by Tech Nation are now employed at leading UK tech firms, helping to fill existing talent gaps, while 28% have launched their own businesses. 

At BenevolentAI you have the chance to work alongside our world-leading experts, building tech which has real impact and contributes directly to our mission to improve patients’ lives. If you are a talented and creative individual interested in joining us on this mission, this could be your answer. 

Start building your career today, and find out more on the Tech Nation Visa guide here. 

Best of luck in your application.

The BenevolentAI Team


More Posts

You Might Also Like

News
BenevolentAI Appoints Daniel Neil as Chief Technology Officer
Daniel Neil has been promoted to Chief Technology Officer to develop BenevolentAI’s long term technology strategy for artificial intelligence-driven drug discovery.
Jan 21, 2022
Blog
World Health Organization panel strongly recommends the use of baricitinib to treat hospitalised patients with COVID-19
The WHO has widened its COVID-19 treatment pool by adding baricitinib, the drug first identified as a COVID-19 treatment by BenevolentAI, to the top of its treatment guideline.
Jan 14, 2022
News
BenevolentAI announces 3-year collaboration expansion with AstraZeneca focused on systemic lupus erythematosus and heart failure
BenevolentAI and AstraZeneca add systemic lupus erythematosus and heart failure to their expanded AI drug discovery collaboration.
Jan 13, 2022
News
BenevolentAI to Present at the 40th Annual JP Morgan Healthcare Conference
Joanna Shields, CEO of BenevolentAI, a clinical-stage AI drug discovery company, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, 10th January.
Jan 6, 2022
Blog
It’s up to us: reflections on responsible innovation
Joanna Shields, CEO BenevolentAI shares her reflection on Responsible AI and innovation following her recent involvement at the GPAI Summit and Paris Peace Forum.
Dec 22, 2021
News
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio
Novel target for idiopathic pulmonary fibrosis, discovered using BenevolentAI’s AI-driven drug discovery platform, selected to enter AstraZeneca’s portfolio.
Dec 15, 2021